HLN
Haleon plc
NYSE: HLN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$9.24
-0.65% today
Updated 2026-04-30
Market cap
$42.18B
P/E ratio
18.98
P/S ratio
3.82x
EPS (TTM)
$0.50
Dividend yield
0.74%
52W range
$9 – $11
Volume
8.4M
Haleon plc (HLN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
15.10%
Operating margin
23.20%
ROE
10.30%
ROA
4.67%
Debt/equity
0.53x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $8.48B | $655.00M | 56.63% | 10.58% | 7.72% |
| 2020 | $9.89B | $1.15B | 59.75% | 16.15% | 11.58% |
| 2021 | $9.54B | $1.39B | 62.34% | 17.16% | 14.56% |
| 2022 | $10.86B | $1.06B | 60.57% | 16.81% | 9.76% |
| 2023 | $11.30B | $1.05B | 61.59% | 17.66% | 9.28% |
| 2024 | $11.23B | $1.44B | 61.85% | 19.64% | 12.84% |
| 2025 | $10.79B | $1.63B | 64.77% | 22.44% | 15.11% |